Penn in the News

“The court’s incremental approach to lawmaking means you’re going to see some opinions that stake out different ground as the law develops,” says Jill Fisch of Penn Carey Law. “That tends to get ironed out over time.”

“Our findings suggest that a temporary increase in testosterone does not meaningfully change people’s ability to override intuitive responses and engage in deliberate reasoning,” says Gideon Nave of the Wharton School.

Female breadwinners who earn more than their husbands face a 36 percent higher risk of splitting up than couples where the man remains the main earner, according to new research from the School of Arts & Sciences.

Reid Mergerl of the Perelman School of Medicine says a further complicating factor in menopause symptoms is the load people must handle at the same time, such as caring for children and aging or ailing parents.

“Cottage cheese is affordable, accessible and nutrient-dense, and sometimes the boring grocery-store staple is actually the better value both financially and nutritionally,” says Colleen Tewksbury of the School of Nursing.

"It does look like it will potentially be the largest El Niño event on record,” says Michael Mann of the School of Arts & Sciences.

As one ages often the sense of taste may diminish, Lisa M. Walke of the Perelman School of Medicine says caution should be used before adding salt to add flavor “You want to be mindful if you do this, particularly if you have medical conditions such as high blood pressure,” says Walke.

“We should be hearing results from multiple studies over the next few years and there’s every reason to hope now, with this news, that many of them will be positive,” says Robert Vonderheide of the Perelman School of Medicine about personalized mRNA vaccines for cancers.

In an opinion piece co-written by Ali Ahmed of the Perelman School of Medicine with Jeff Taylor and Jeff Berry the trio note that in their work "with long-term survivors, community advisory boards, and discussions about a cure, we have heard a recurring concern that deserves far more policy attention: What if a cure — or durable control, where the virus remains in the body, but at such low levels that it doesn’t cause problems and cannot be transmitted — is treated as proof that support for patients is no longer needed?

"We need better ways to prevent recurrence for patients in remission. Recurrence of cancer is a most dreaded event," says Robert Vonderheide of Penn Medicine. "A vaccine to mobilize the immune system to guard against recurrence would be a gamechanger. This news means such a vaccine is probably closer to reality than we thought."